Buried by Agreement: The Corporate Practice of Settling Scandals Into Silence

In the spring of 2017, a mid-sized pharmaceutical distributor in Ohio agreed to pay $36 million to settle claims brought by several counties alleging that its distribution practices had contributed to the region's opioid crisis. The settlement was reported as a legal victory. What was not reported — because the agreement prohibited it — were the internal documents the company had produced during discovery: emails, shipping records, and compliance reports that plaintiffs' attorneys described in court filings as evidence of deliberate disregard for suspicious order patterns.

Those documents remain sealed. The regulators who oversee pharmaceutical distribution never received them. The communities still living with the consequences of the opioid epidemic have no access to them. The company, for its part, admitted no wrongdoing.

This is settlement confidentiality — and it is one of the most consequential and least examined features of the American civil justice system.

The Mechanics of Managed Silence

Corporate defendants have powerful incentives to attach confidentiality provisions to civil settlements. Beyond the obvious interest in limiting reputational damage, sealed agreements prevent the evidence developed in one lawsuit from being used in subsequent litigation. A plaintiff injured by a defective product who cannot access documents from a prior settlement must essentially rebuild the evidentiary case from scratch — a process that favors the defendant's superior resources and institutional memory.

The strategic value of this dynamic has not been lost on corporate legal departments. A body of scholarship examining mass tort litigation — asbestos, tobacco, pharmaceutical products, automotive defects — has documented a recurring pattern: early settlements with confidentiality provisions, followed by continued sales of the harmful product, followed by additional injuries, followed by additional settlements, each iteration sealed from the next.

In the tobacco litigation of the 1980s and early 1990s, internal documents establishing that major manufacturers had known for decades about the addictive properties and health harms of cigarettes sat sealed in settlement agreements for years before a separate wave of state attorneys general litigation finally forced their disclosure. The public health implications of that concealment — in terms of continued marketing, continued sales, and delayed regulatory action — are difficult to fully quantify but impossible to dismiss.

Confidentiality as Regulatory Evasion

The implications extend beyond individual cases. When corporate misconduct is resolved through sealed civil settlements rather than regulatory enforcement or criminal prosecution, the institutional knowledge generated by litigation — the documents, the depositions, the expert analyses — vanishes from the public record. Regulators at the EPA, OSHA, the Consumer Product Safety Commission, and other agencies are left to detect and investigate the same patterns of conduct independently, without the benefit of evidence that private litigation has already assembled.

Legal scholars have described this as a form of structural information suppression. Professor Arthur Miller of New York University School of Law, one of the leading authorities on civil procedure, has written that confidential settlements "privatize the public function of courts" — transforming judicial proceedings that are nominally public institutions into instruments of managed concealment.

The consequences are not evenly distributed. Large corporations with sophisticated legal teams and substantial settlement budgets can systematically resolve liability exposure while suppressing the documentary record of their conduct. Smaller defendants, and individuals, rarely have access to the same tools.

The Workplace Dimension

The dynamics of settlement confidentiality play out with particular force in employment litigation. Workplace harassment and discrimination cases settled under confidentiality agreements have, in numerous documented instances, allowed serial offenders to move between employers while their conduct history remained invisible to new employers and potential victims.

The #MeToo movement brought renewed attention to this dimension of the problem, prompting Congress to pass the Speak Out Act in 2022, which restricts the enforceability of pre-dispute nondisclosure agreements in sexual harassment and assault cases. The law represented a meaningful reform in a narrow context. But it left intact the broader architecture of post-dispute settlement confidentiality, and it did not address the wide range of other misconduct categories — wage theft, racial discrimination, retaliation against whistleblowers — where the same dynamics operate.

The Reform Argument

A coalition of public interest organizations, plaintiffs' attorneys, and legal academics has coalesced around several reform proposals. The most sweeping would require judicial approval of any settlement confidentiality provision — a standard that exists in some form in Florida, Texas, and a handful of other states but has not been adopted nationally. Under this framework, a court would have to affirmatively find that the public interest is not harmed by sealing before a confidentiality provision could take effect.

A narrower proposal, advanced by several consumer advocacy organizations, would prohibit confidentiality provisions in settlements involving ongoing public safety risks — a category that would encompass environmental contamination, defective products, and pharmaceutical harms, among others. This approach attempts to preserve legitimate confidentiality interests — protecting genuinely proprietary information, shielding innocent third parties — while preventing the use of sealed agreements to suppress evidence of continuing dangers.

Opponents of reform, including business associations and some defense-side legal organizations, argue that confidentiality provisions are often essential to reaching settlements at all — that defendants who cannot protect sensitive business information will litigate cases to verdict rather than settle, producing outcomes that are more costly and less certain for all parties.

There is some empirical support for this concern. But critics counter that the current system has inverted the proper relationship between private resolution and public accountability — allowing the civil justice system to function as a mechanism for laundering corporate misconduct rather than deterring it.

The sealed documents in Ohio still sit wherever sealed documents go. The pattern they document, in all likelihood, has repeated itself elsewhere. That is, in the end, the precise function that confidentiality was designed to serve.